Sign in

Alex Dimitrief

Director at Eos Energy Enterprises
Board

About Alex Dimitrief

Independent director since 2020; age 66. Chair of the Nominating & Corporate Governance Committee and member of the Audit Committee. Background includes GE General Counsel (2015–2018), President/CEO of GE Global Growth Organization, and 20 years as a senior partner at Kirkland & Ellis LLP. Education: B.A. Yale College; J.D. Harvard Law School; current roles include SVP & General Counsel at Sotera Health (Nasdaq: SHC), partner at Zeughauser Group, and Global Chair of Ronald McDonald House Charities (appointed Jan 2025) .

Past Roles

OrganizationRoleTenureCommittees/Impact
General Electric (GE)General Counsel2015–2018Led global legal, compliance, SEC reporting, government affairs, environmental safety; principal advisor to GE board
GE Global Growth OrganizationPresident & CEO2018Drove growth in 180+ countries; $76B international orders in 2018; financing for emerging market customers
GE CapitalTransformation leaderPrior to 2015Led transformation of GE Capital; governance and risk roles
GE Energy (China/Russia)JV negotiations leaderPrior to 2015Led joint venture negotiations
Kirkland & Ellis LLPSenior partner~1987–2007Advised boards on securities, restructuring, IP, product liability, environmental, governance, commercial disputes

External Roles

OrganizationRoleTenureNotes
Sotera Health Co. (Nasdaq: SHC)SVP & General CounselSince Nov 2022Public company role
Zeughauser GroupPartnerCurrentAdvises law firms/legal departments
Ronald McDonald House CharitiesGlobal ChairAppointed Jan 2025Non-profit leadership
Prior public boardsDirectorPriorThe We Company; Synchrony Financial (NYSE: SYF); SmileDirectClub (Nasdaq: SDC); GE Capital Bank

Board Governance

  • Committee assignments: Chair, Nominating & Corporate Governance; Member, Audit .
  • Independence: Board determined Alex is independent under Nasdaq rules .
  • Board leadership: Independent Chair (Russell Stidolph); independent director executive sessions ≥2/year .
  • Meetings and attendance: Board met 26 times in FY2024; Audit (4), Compensation (5), Nominating & Governance (6); overall Board/committee attendance 81% .

Fixed Compensation

Component (FY2024)Amount (USD)Notes
Annual cash retainer$25,000 Paid quarterly in arrears
Committee chair fee (Nominating & Governance)Included in stock award valueChair RSU grant policy value $25,000 (RSUs)
Meeting feesNone disclosedPolicy does not specify meeting fees

Performance Compensation

Component (FY2024)Grant-Date Fair Value (USD)Vesting/Structure
Annual equity retainer (RSUs)$160,263 RSUs only from 2024; vest on earlier of 1 year or before next annual meeting; accelerated on change in control
Chair RSUs (N&G Chair)Included in stock awardChair grants RSUs valued at $25,000 for N&G chair (effective beginning 2024 service year)
Options$0 No director option grants in 2024; aggregate options outstanding disclosed separately

Performance metrics: None for directors; director equity is time-based RSUs (no PSUs/options in 2024) .

Clawback and change-in-control: All awards subject to company clawback policies; non-employee director awards generally accelerate on single trigger if not assumed in a change in control; employees have double-trigger treatment .

Other Directorships & Interlocks

CompanyRoleTypePotential Interlock/Conflict
The We CompanyDirector (prior)Public/PrivateNone disclosed with Eos
Synchrony Financial (NYSE: SYF)Director (prior)PublicNone disclosed with Eos
SmileDirectClub (Nasdaq: SDC)Director (prior)PublicNone disclosed with Eos
GE Capital BankDirector (prior)BankNone disclosed with Eos
Sotera Health Co. (Nasdaq: SHC)SVP & General Counsel (current)PublicExecutive role at another public company; no related-party transactions disclosed

Expertise & Qualifications

  • Deep legal, governance, compliance, and global operations expertise; recognized by GE leadership for integrity and transparency .
  • Prior board experience across multiple public companies; experienced with complex financing, international growth, and risk management .
  • Legal education and teaching roles in corporate law; extensive board advisory background .

Equity Ownership

MetricMar 1, 2024Mar 1, 2025Aug 12, 2025
Beneficial ownership (shares)444,994 454,994 502,099
% of outstanding<1% <1% <1%

Outstanding awards (as of Dec 31, 2024):

  • RSUs outstanding: 92,105
  • Options outstanding: 272,647

Policies:

  • Hedging/pledging prohibited for directors under the Insider Trading Policy .

Governance Assessment

  • Strengths: Independent status; chairs governance committee overseeing related person transactions; substantial legal/governance expertise; hedging/pledging prohibited; clear director compensation policy anchored in RSUs with standard vesting and change-in-control terms .
  • Alignment: Holds equity; beneficial ownership increased across 2024–2025; director equity retainer paid in stock (RSUs) fosters alignment .
  • Attendance/engagement: Board/committee overall attendance 81% in 2024 – monitor engagement levels; no individual attendance disclosed .
  • Conflicts/related party: No Dimitrief-specific related-party transactions disclosed; Cerberus financing introduced Preferred Directors and governance rights, but Dimitrief is not affiliated; governance committee (chaired by Dimitrief) reviews related-person transactions .
  • Compensation structure evolution: Shift to all-RSU director equity from 2024 (away from options) aligns with best practices and lowers risk; chair RSUs formalized; no options granted in 2024 .

RED FLAGS to monitor: Overall attendance metric (81%) below typical large-cap norms; enhanced investor-preferred board rights via Cerberus agreements may affect board dynamics—ensure robust independence and oversight remains in place .